Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TIL-based Therapy Market (2nd Edition), 2023-2035.”
The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:
- A detailed assessment of the current market landscape of TIL-based therapies.
- A detailed analysis of completed, ongoing and planned clinical studies related to TIL-based therapies.
- An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies.
- Elaborate profiles of mid- to late-stage clinical products (phase I/II or above).
- An analysis of various type of partnership that have been inked between several stakeholders in the domain of TIL therapies.
- An analysis of the investments that have been made into companies that have proprietary TIL-based products / technologies.
- An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022.
- A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.
- An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.
- Elaborate profiles of the several leading players in the domain of TCR cell therapies.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
- Target Indication(s)
- Melanoma
- Head and Neck Carcinoma
- Chronic Lymphocytic Leukemia
- Sarcoma
- Hepatocellular Carcinoma
- Breast Cancer
- Acute Myeloid Leukemia
- Cervical Carcinoma
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TIL-based product(s), such as information on status of development, technology portfolio (if available), recent developments related to TIL-based therapies and manufacturing capabilities of the players.
- Cellectis
- Cellular Biomedicine Group
- Iovance Biotherapeutics
- Lytix Biopharma
- Phio Pharmaceuticals
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities |
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
